Galmed Pharmaceuticals Ltd. (GLMD)

NCM – Real Time Price. Currency in USD

0.56

-0.00 (-0.73%)

Market open: Aug 12, 2026, 11:19 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

Total Revenue

Cost of goods sold

-83K

Gross Profit

-83K

Operating expenses (excl. COGS)

-9M

-6M

Operating Income

-9M

-6M

Non-operating income, total

-2M

-1M

Pretax income

-10M

-8M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-10M

-8M

Discontinued operations

Net income

-10M

-8M

Dilution adjustment

Preferred dividends

Galmed Pharmaceuticals Ltd. (GLMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Galmed Pharmaceuticals Ltd. (GLMD)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Galmed Pharmaceuticals Ltd. (GLMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Galmed Pharmaceuticals Ltd. (GLMD)

Income Statement (Annual)

Income Statement (Annual)